How long does it take for Besudil to take effect? How long does it take for patients to see results after using this drug?

Belumosudil (Belumosudil) is a ROCK2 (Rho-related protein kinase 2) inhibitor, mainly used to treat chronic graft-versus-host disease (cGVHD). Since cGVHD is a complex immune system disease, the time it takes for patients to take besudil may vary depending on the severity of the disease, individual immune response, and concomitant medications.

Generally speaking, some patients may begin to see signs of symptom relief, such as improvements in skin, joint or digestive system-related symptoms, within 4 to 8 weeks after taking Besudil. Clinical trial data show that after 12 weeks of treatment, about 50%-70% of patients can achieve objective remission (ORR), that is, the symptoms of cGVHD are relieved and the quality of life is improved. For some patients with mild symptoms, a certain effect may be felt in about 4 weeks, while for patients with more severe symptoms or long-term drug resistance, it may take longer.

In addition, the efficacy of besudil depends not only on the duration of administration, but also on dose adjustment and individual immune system response. Doctors usually evaluate the patient's condition regularly during treatment and adjust the dose or combine it with other treatments based on response. If the patient does not see significant results within 3-6 months, the doctor may consider changing or adding other treatments. Therefore, while taking besudil, patients need to be reviewed regularly to monitor disease progression and drug response.

It is worth noting that even after the effect is achieved, patients still need to continue taking it as recommended by their doctor to maintain the treatment effect and reduce the risk of disease recurrence. Some patients may try to gradually reduce the dose or discontinue the drug after their symptoms stabilize, but this must be done under the guidance of a doctor to avoid the recurrence or worsening of cGVHD. Overall, besudil typically demonstrates efficacy within weeks to months, but each patient's circumstances are different and require individualized treatment adjustments.

Reference materials:https://www.rezuomib.com/